Nanosonics Company Description

Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific.

It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories.

The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing.

The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Nanosonics Limited

Country	Australia
Founded	2000
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	508
CEO	Michael Kavanagh

Contact Details

Address: Building A Macquarie Park, NSW 2113 Australia
Phone	61 2 8063 1600
Website	nanosonics.com.au

Stock Details

Ticker Symbol	NAN
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000NAN9
SIC Code	3845

Key Executives

Name	Position
Michael C. Kavanagh BSc, M.B.A.	Chief Executive Officer, President, MD and Executive Director
Jason Burriss B.Com., C.A.	Chief Financial Officer
Rod Lopez M.B.A.	Chief Operating Officer
Derek Minihane BSEE, J.D.	Chief Technology Officer
Sunny Pillai M.B.A.	Chief Information Officer
Jonathan Burdach Ph.D.	Chief Medical Affairs and Scientific Officer
Catherine Strong	Head of Investor Relations and Corporate Communications
Matthew Carbines B.Com., L.L.B.	General Counsel and Company Secretary
Kimberly Hill B.Sc.	Chief Marketing Officer and Regional President of Asia Pacific
Jodi Sampson M.A.I.C.D., M.B.A.	Chief People and Culture Officer